General Purpose Cell Encapsulation Device
- Protects cells in the device from autoimmune destruction
- Inhibits cell-to-cell contact and associated cell signals
- High membrane permeability to oxygen, nutrients andsecreted proteins
Options
| Order code | Description | Size | Sterile |
| 505395 | TheraCyte Implantable Cell Device | 4.5 μL | Yes |
| 505396 | TheraCyte Implantable Cell Device | 20 μL | Yes |
| 505397 | TheraCyte Implantable Cell Device | 40 μL | Yes |
| 505398 | TheraCyte Implantable Cell Device, 4 ports | 40 μL | Yes |
BENEFITS
- No immune suppression needed to keep thetransplanted cells safe
- Allows for the easy implantation of all cells in oneprocedure
- Drug/protein evaluations can be terminated by deviceremoval
- The ability to execute a complete cell removal, byextracting the device, provides a significant safetybenefit
- Allows cells to be nourished through the normal hostblood supply
APPLICATIONS
- Diabetes
- Gene Therapy
- Therapeutic ProteinDelivery
- Protein Discovery
- Immunological Research
- Antibody Delivery
- Cell Transplantation
- Cell Differentiation
- Cytokine Therapy
- Pain Management
- Immunotherapy
- Cancer Therapy
- In Vivo Diagnostics
- Continuous ProteinDelivery
The TheraCyte device delivers high molecular proteins ofat least 900,000 Daltons, and it can be used for any samespecies cells research, without immune suppression orxenographs with immune suppression. It is perfect forthe delivery of proteins that are unstable and difficultto manufacture or purify. TheraCyte devices offercontinuous protein delivery.
20 Years of published, peer-reviewed research
TheraCyte is the only branded general purpose cellencapsulation device available worldwide to all researchers.It is the gold standard cell encapsulation device with 20 yearsof published peer reviewed research. With proven technique andprocess to support the development of new cell lines and proteinresearch, TheraCyte has developed an international reputationas a high quality brand.
TheraCyte cell encapsulation devices enable the developmentof cell-based therapeutic products for treating chronic andrecurrent diseases including diabetes, infection control, proteindeficiencies and immunological disorders.
The TheraCyte™ system for encapsulating and transplanting cellsis a thin membrane-based polymeric chamber. It is fabricatedfrom biocompatible membranes which protect allogeneiccells from rejection by the recipient and, when implantedsubcutaneously, induce the development of blood capillariesclose to the membranes. This vascularization feature provides arich blood supply to nourish the tissues within the membranes,aids in the communication of implanted cells with the host andassures rapid uptake of therapeutic molecules.
Cell Encapsulation - an overview | ScienceDirect Topics. (n.d.). Retrieved March 19, 2020, from https://www.sciencedirect.com/topics/medicine-and-dentistry/cell-encapsulation
